Header Logo

Connection

SUSAN BLANEY to Piperidines

Back to Details
This is a "connection" page, showing publications SUSAN BLANEY has written about Piperidines.
SUSAN BLANEY
Connection Strength
0.064
Piperidines
  1. Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium Study. J Clin Oncol. 2007 Jul 20; 25(21):3137-43.
    View in: PubMed
    Score: 0.064
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.